Working… Menu

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04354246
Recruitment Status : Recruiting
First Posted : April 21, 2020
Last Update Posted : August 4, 2021
Information provided by (Responsible Party):
Compugen Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2021
Estimated Study Completion Date : September 30, 2022